Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
174,282,170
-
Total 13F shares
-
16,160
-
Share change
-
0
-
Total reported value
-
$143,178
-
Price per share
-
$8.86
-
Number of holders
-
1
Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q4 2023
As of 31 Dec 2023,
Prime Medicine, Inc. - COMMON STOCK (PRME) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
16,160 shares.
The largest 10 holders included
Alphabet Inc., VANGUARD GROUP INC, FMR LLC, BlackRock Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ARK Investment Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, MWG Management Ltd., and Redmile Group, LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.